Technology Sectors & Industries
Pharmaceuticals
Filter
Dr Anna Constantinou
Anna obtained a BSc in Chemistry from the Department of Chemistry at the University of Cyprus in 2014 and an MSc in Advanced Materials in 2015 from the Department of Materials at Imperial College. Her Masters thesis was entitled "Thermo-responsive Gels based on ABC...
Dr Theoni K. Georgiou
Human monoclonal antibodies to COVID-19
A suite of broad neutralising monoclonal antibodies (bnMABs) isolated to be used for treatment of coronaviruses with a focus on SARS-CoV-2 (2019-nCoV).
Two distinct late stage preclinical lead series of highly specific inhibitors of MAP4K4
A late-stage, pre-clinically validated inhibitor of MAP4K4 for a range of indications including anthracycline cardiotoxicity
Professor Michael Schneider
Management of pre-term labour via an application for pathway selective EP2 agonist
An EP2 receptor agonist with an application as a novel tocolytic for the management of pre-term labour.
Complement Factor H Knock Out Mouse Model
In the field of eye disease, such as age-related macular degeneration (AMD) this mouse model has been proven important for research into the mechanisms of disease. This disease model is useful for conditions in which complement factor H plays a role.
Traction force-activated therapeutics (TrAPs)
An engineered platform for controllable, “cell-activated” therapeutic delivery.
Professor Jason Hallett
Sign up for updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.